Optimal designs for dose-escalation trials and individual allocations in cohorts
From MaRDI portal
(Redirected from Publication:2084331)
Recommendations
- The construction of optimal designs for dose-escalation studies
- Optimal designs for dose-finding studies
- On recent advances in optimal allocation designs in clinical trials
- Optimal approximate designs for comparison with control in dose-escalation studies
- Optimal designs for active controlled dose-finding trials with efficacy-toxicity outcomes
- Optimal allocation of patients in titration to fixed dose trials
- scientific article; zbMATH DE number 1361707
- A comparison of allocation strategies for optimising clinical trial designs under variance heterogeneity
- Implementing optimal allocation in clinical trials with multiple endpoints
Cites work
- scientific article; zbMATH DE number 3911522 (Why is no real title available?)
- scientific article; zbMATH DE number 3478255 (Why is no real title available?)
- scientific article; zbMATH DE number 1151381 (Why is no real title available?)
- scientific article; zbMATH DE number 800961 (Why is no real title available?)
- A Treatment Allocation Procedure for Sequential Clinical Trials
- CONOPT: A GRG code for large sparse dynamic nonlinear optimization problems
- Coherence principles in dose-finding studies
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Convexification and global optimization in continuous and mixed-integer nonlinear programming. Theory, algorithms, software, and applications
- Design and Analysis of Phase I Clinical Trials
- Designs with Partial Factorial Balance
- Differentiating the pseudo determinant
- Dynamic Treatment Allocation Adjusting for Prognostic Factors for More Than Two Treatments
- Global optimization problems in optimal design of experiments in regression models
- Model building in mathematical programming.
- On inverting circulant matrices
- Optimal Bayesian-feasible dose escalation for cancer phase I trials
- Optimal approximate designs for comparison with control in dose-escalation studies
- Optimal designs for comparing test treatments with controls. With comments and a rejoinder by the authors
- Optimal designs for dose-finding studies
- Optimal exact designs of experiments via mixed integer nonlinear programming
- Optimum biased coin designs for sequential clinical trials with prognostic factors
- Optimum experimental designs, with SAS
- Properties of biased coin designs in sequential clinical trials
- Statistical Issues in Drug Development
- Symmetry breaking in mixed integer linear programming formulations for blocking two-level orthogonal experimental designs
- The Comparison of Designs for Sequential Clinical Trials with Covariate Information
- The construction of optimal designs for dose-escalation studies
Cited in
(6)- Optimal approximate designs for comparison with control in dose-escalation studies
- The construction of optimal designs for dose-escalation studies
- Cumulative cohort design for dose-finding
- Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment
- Efficient design and inference for multistage randomized trials of individualized treatment policies
- Optimal designs for active controlled dose-finding trials with efficacy-toxicity outcomes
This page was built for publication: Optimal designs for dose-escalation trials and individual allocations in cohorts
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2084331)
